New Developments in Pancreatic Cancer Treatment
Pancreatic cancer remains one of the most difficult cancers to treat. However, advances in genetics, targeted drugs, and immunotherapy are creating new possibilities.
Some newer treatments are already available to selected patients. Others remain experimental.
Targeted Therapy: A Major Advance
Traditional chemotherapy attacks rapidly dividing cells. Targeted therapies interfere with specific proteins or genetic changes that help cancer cells grow.
One important target is KRAS, a gene altered in approximately 90% of pancreatic ductal cancers.
For decades, researchers struggled to develop drugs that could block abnormal KRAS proteins. New inhibitors are now showing encouraging results in clinical trials.
One investigational drug, daraxonrasib, targets abnormal RAS proteins. Early studies have reported promising results in advanced pancreatic cancer, although further research is needed to establish its benefits and risks.
Personalized Medicine and Genetic Testing
Not all pancreatic cancers have the same genetic characteristics.
Testing inherited genes and the tumor itself can sometimes identify additional treatment options.
For example:
BRCA mutations: Some patients may benefit from platinum-based chemotherapy or olaparib.
Rare genetic alterations: Changes involving genes such as NTRK may make targeted drugs appropriate.
Other molecular characteristics: Certain tumors may respond to immunotherapy.
These possibilities make genetic and molecular testing increasingly important.
Immunotherapy
Immunotherapy helps the immune system recognize and attack cancer cells.
Although it has transformed treatment for some cancers, most pancreatic cancers have responded poorly.
However, a small percentage of tumors have characteristics such as MSI-H or dMMR that may make them responsive to immunotherapy.
Researchers are studying combinations of immunotherapy, chemotherapy, and targeted drugs to improve results.
Cancer Vaccines
Experimental cancer vaccines are designed to teach the immune system to recognize pancreatic cancer cells.
Some are personalized using genetic information from a patient's tumor.
Early studies have shown encouraging immune responses, but cancer vaccines have not yet been established as effective treatments for pancreatic cancer.
Larger clinical trials are underway.
Other Promising Approaches
Researchers are also investigating:
Cell therapies that activate immune cells against cancer.
New combinations of targeted drugs and immunotherapy.
Treatments that change the environment surrounding pancreatic tumors.
New chemotherapy combinations designed to overcome drug resistance.
Most remain experimental.
High-Dose Intravenous Vitamin C
A small randomized clinical trial published in 2024 reported that patients with advanced pancreatic cancer receiving high-dose intravenous vitamin C alongside chemotherapy had a median survival of 16 months, compared with 8.3 months for those receiving chemotherapy alone.
Although encouraging, these findings require confirmation in larger studies.
Clinical Trials
Clinical trials evaluate promising new treatments and may offer options not otherwise available.
Patients should consider discussing clinical trials early in their treatment planning, particularly at specialized pancreatic cancer centers.
What About Older Adults?
Age alone should not exclude someone from newer treatments or clinical trials.
However, treatment decisions should consider overall health, possible side effects, independence, and quality of life.
Patients in their 70s and 80s should ask whether a treatment has been studied in people of similar age and health.
The Important Point
Pancreatic cancer research is making progress, particularly in targeted therapies and personalized medicine.
The challenge is distinguishing treatments with demonstrated benefits from promising approaches that remain experimental.
Learn More
New treatments and research developments.
Find clinical trials for pancreatic cancer.
Innovative pancreatic cancer research.
A leading nonprofit organization supporting pancreatic cancer research, early detection, and improved treatments. PanCAN provides free, personalized assistance to patients and families, including information about treatment options, genetic testing, clinical trials, and nutrition. It also funds innovative research through programs such as Precision Promise and advocates for increased federal cancer research funding.
Clinical trials of promising new treatments.
Funds innovative research into early detection, new treatments, cancer biology, and metabolism. Its programs include research grants, educational webinars, and an annual symposium at UCLA featuring leading researchers and physicians. The foundation also provides practical and financial support for patients and families.